Drug Master Files for: LINAGLIPTIN
✉ Email this page to a colleague
LINAGLIPTIN Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 27907 | A | II | 3/24/2014 | GLENMARK PHARMACEUTICALS LTD | LINAGLIPTIN |
| 28098 | A | II | 3/28/2014 | MSN PHARMACHEM PRIVATE LTD | LINAGLIPTIN [ROUTE CODE LG] |
| 28404 | A | II | 6/26/2014 | BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD | LINAGLIPTIN |
| 28748 | A | II | 10/31/2014 | MYLAN LABORATORIES LTD | LINAGLIPTIN |
| 28766 | A | II | 11/19/2014 | ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD | LINAGLIPTIN |
| 28767 | A | II | 1/30/2015 | DR REDDYS LABORATORIES LTD | LINAGLIPTIN |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
